Related references
Note: Only part of the references are listed.Improving silymarin oral bioavailability using silica-installed redox nanoparticle to suppress inflammatory bowel disease
Thu-Ha Thi Nguyen et al.
JOURNAL OF CONTROLLED RELEASE (2021)
Compound sophorae decoction enhances intestinal barrier function of dextran sodium sulfate induced colitis via regulating notch signaling pathway in mice
Hui Wu et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
β-1,3-D-Glucan based yeast cell wall system loaded emodin with dual-targeting layers for ulcerative colitis treatment
Xiulan Pu et al.
CARBOHYDRATE POLYMERS (2021)
Monosexual Cercariae of Schistosoma japonicum Infection Protects Against DSS-Induced Colitis by Shifting the Th1/Th2 Balance and Modulating the Gut Microbiota
Hongli Zhou et al.
FRONTIERS IN MICROBIOLOGY (2021)
Luteolin alleviates inflammation and modulates gut microbiota in ulcerative colitis rats
Bolin Li et al.
LIFE SCIENCES (2021)
Heme-Oxygenase-1 Attenuates Oxidative Functions of Antigen Presenting Cells and Promotes Regulatory T Cell Differentiation during Fasciola hepatica Infection
Monique Costa et al.
ANTIOXIDANTS (2021)
Reductively modified albumin attenuates DSS-Induced mouse colitis through rebalancing systemic redox state
Xiawen Yang et al.
REDOX BIOLOGY (2021)
Oxidative stress response in regulatory and conventional T cells: a comparison between patients with chronic coronary syndrome and healthy subjects
Anna K. Lundberg et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2021)
Colon‐Targeted Adhesive Hydrogel Microsphere for Regulation of Gut Immunity and Flora (Adv. Sci. 18/2021)
Hua Liu et al.
Advanced Science (2021)
Cancer-Preventive Role of Bone Marrow-Derived Mesenchymal Stem Cells on Colitis-Associated Colorectal Cancer: Roles of Gut Microbiota Involved
Ruohang He et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
The kinase PDK1 regulates regulatory T cell survival via controlling redox homeostasis
Peiran Feng et al.
THERANOSTICS (2021)
Recent Advances of D-α-tocopherol Polyethylene Glycol 1000 Succinate Based Stimuli-responsive Nanomedicine for Cancer Treatment
Yang Guan et al.
CURRENT MEDICAL SCIENCE (2020)
Oxymatrine loaded nitric oxide-releasing liposomes for the treatment of ulcerative colitis
Qing Tang et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)
Luteolin ameliorates experimental colitis in mice through ERK-mediated suppression of inflammation, apoptosis and autophagy
Iva Vukelic et al.
FOOD AND CHEMICAL TOXICOLOGY (2020)
Therapeutic Opportunities in Inflammatory Bowel Disease: Mechanistic Dissection of Host-Microbiome Relationships
Damian R. Plichta et al.
CELL (2019)
High Glucose Intake Exacerbates Autoimmunity through Reactive-Oxygen-Species-Mediated TGF-β Cytokine Activation
Dunfang Zhang et al.
IMMUNITY (2019)
A Proresolving Peptide Nanotherapy for Site-Specific Treatment of Inflammatory Bowel Disease by Regulating Proinflammatory Microenvironment and Gut Microbiota
Chenwen Li et al.
ADVANCED SCIENCE (2019)
A Novel Immunosuppressant, Luteolin, Modulates Alloimmunity and Suppresses Murine Allograft Rejection
Shulin Ye et al.
JOURNAL OF IMMUNOLOGY (2019)
Effect of compound sophorae decoction on dextran sodium sulfate (DSS)-induced colitis in mice by regulating Th17/Treg cell balance
Meng Xu et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Mechanisms of Disease: Inflammatory Bowel Diseases
Guilherme Piovezani Ramos et al.
MAYO CLINIC PROCEEDINGS (2019)
ACG Clinical Guideline: Ulcerative Colitis in Adults
David T. Rubin et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2019)
Dual expression of CXCR4 and IL-35 enhances the therapeutic effects of BMSCs on TNBS-induced colitis in rats through expansion of Tregs and suppression of Th17 cells
Zhen Nan et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Luteolin attenuates airway inflammation by inducing the transition of CD4+ CD25- to CD4+ CD25+ regulatory T cells
Seung-Hyung Kim et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
Nanoparticle-Based Oral Drug Delivery Systems Targeting the Colon for Treatment of Ulcerative Colitis
Mingzhen Zhang et al.
INFLAMMATORY BOWEL DISEASES (2018)
Evidence-based clinical practice guidelines for inflammatory bowel disease
Katsuyoshi Matsuoka et al.
JOURNAL OF GASTROENTEROLOGY (2018)
ROS-responsive drug delivery systems for biomedical applications
Wenhui Tao et al.
ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
Reactive-Oxygen-Species-Responsive Drug Delivery Systems: Promises and Challenges
Gurusamy Saravanakumar et al.
ADVANCED SCIENCE (2017)
Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies
Siew C. Ng et al.
LANCET (2017)
Chemically induced mouse models of acute and chronic intestinal inflammation
Stefan Wirtz et al.
NATURE PROTOCOLS (2017)
Nanoparticle curcumin ameliorates experimental colitis via modulation of gut microbiota and induction of regulatory T cells
Masashi Ohno et al.
PLOS ONE (2017)
Recent developments in D-α-tocopheryl polyethylene glycol-succinate-based nanomedicine for cancer therapy
Songwei Tan et al.
DRUG DELIVERY (2017)
A superoxide dismutase/catalase mimetic nanomedicine for targeted therapy of inflammatory bowel disease
Qixiong Zhang et al.
BIOMATERIALS (2016)
Luteolin ameliorates dextran sulfate sodium-induced colitis in mice possibly through activation of the Nrf2 signaling pathway
Yue Li et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2016)
RNA interference-based nanosystems for inflammatory bowel disease therapy
Jian Guo et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2016)
Gastrointestinal mucosal barrier function and diseases
Tadayuki Oshima et al.
JOURNAL OF GASTROENTEROLOGY (2016)
Self-Assembled Redox Dual-Responsive Prodrug-Nanosystem Formed by Single Thioether-Bridged Paclitaxel-Fatty Acid Conjugate for Cancer Chemotherapy
Cong Luo et al.
NANO LETTERS (2016)
Loss of Response to Anti-TNFs: Definition, Epidemiology, and Management
Giulia Roda et al.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2016)
Nanoparticles With Surface Antibody Against CD98 and Carrying CD98 Small Interfering RNA Reduce Colitis in Mice
Bo Xiao et al.
GASTROENTEROLOGY (2014)
pH-Sensitive Nanoparticles of Curcumin-Celecoxib Combination: Evaluating Drug Synergy in Ulcerative Colitis Model
Dalapathi Gugulothu et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2014)
Review article: the role of oxidative stress in pathogenesis and treatment of inflammatory bowel diseases
Aleksandra Piechota-Polanczyk et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2014)
OXIDATIVE STRESS: AN ESSENTIAL FACTOR IN THE PATHOGENESIS OF GASTROINTESTINAL MUCOSAL DISEASES
Asima Bhattacharyya et al.
PHYSIOLOGICAL REVIEWS (2014)
Inhibition of Th1/Th17 responses via suppression of STAT1 and STAT3 activation contributes to the amelioration of murine experimental colitis by a natural flavonoid glucoside icariin
Feifei Tao et al.
BIOCHEMICAL PHARMACOLOGY (2013)
Multifunctional polymeric nanoparticles for oral delivery of TNF-α siRNA to macrophages
Chunbai He et al.
BIOMATERIALS (2013)
Prevention of selenite induced oxidative stress and cataractogenesis by luteolin isolated from Vitex negundo
B. N. Rooban et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2012)
Functional relevance of T helper 17 (Th17) cells and the IL-17 cytokine family in inflammatory bowel disease
Gheorghe Hundorfean et al.
INFLAMMATORY BOWEL DISEASES (2012)
IL-23/IL-17 Axis in IBD
Massimiliano Sarra et al.
INFLAMMATORY BOWEL DISEASES (2010)
All-Trans Retinoic Acid Ameliorates Trinitrobenzene Sulfonic Acid-Induced Colitis by Shifting Th1 to Th2 Profile
Aiping Bai et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2010)
IκBζ regulates TH17 development by cooperating with ROR nuclear receptors
Kazuo Okamoto et al.
NATURE (2010)
Orally delivered thioketal nanoparticles loaded with TNF-α-siRNA target inflammation and inhibit gene expression in the intestines
D. Scott Wilson et al.
NATURE MATERIALS (2010)
Distribution and Biological Activities of the Flavonoid Luteolin
Miguel Lopez-Lazaro
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2009)
Disorders of a modern lifestyle: reconciling the epidemiology of inflammatory bowel diseases
Charles N. Bernstein et al.
GUT (2008)
Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice
WT Huang et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
The immunological and genetic basis of inflammatory bowel disease
G Bouma et al.
NATURE REVIEWS IMMUNOLOGY (2003)
Increased expression of interleukin 17 in inflammatory bowel disease
S Fujino et al.
GUT (2003)
Inflammatory bowel disease
DK Podolsky
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Dietary agents in cancer prevention: flavonoids and isoflavonoids
DF Birt et al.
PHARMACOLOGY & THERAPEUTICS (2001)
Share Paper
